Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 1, 2021
FDA Warns Seller of Saffron Supplements
On November 18th, 2021, the FDA issued a warning letter to Saffron Health Sciences following a review of the company's website, social media, and Amazon product listings, which found statements made about the company's products Crocin Rich, Crocin Rich II, and Crocin Rich Plus to be drug claims.
For example, these Crocin supplements were promoted with statements such as "Crocin supplements are designed for...Alzheimer's...Macular degeneration (AMD), diabetic maculopathy" and "Crocin, the unique water-soluble carotenoid with potent...anti-inflammation effects, could be a promising natural agent to boost immune system and body defense against COVID-19."
Crocin Rich Plus and Crocin Rich II were promoted with statements such as "CROCIN RICH II is Good For...Help recovery of nerve and traumatic injury."
(See ConsumerLab's answer to the question: Does saffron really improve vision or prevent age-related macular degeneration? and the Saffron section in our Vision Supplements Review for information about saffron.)
In addition, these products were found to be misbranded because they do not contain adequate directions for their intended use, as required by federal regulations.
For more information, use the link below.
See related warnings: